Infants Clinical Trial
Official title:
Effect of Consumption of a Milk Product Designed for Lactating Women on Human Milk Composition and Nutritional Status of Iron and DHA in Infant Red Blood Cells.. Study in a Vulnerable Population.
NCT number | NCT06319079 |
Other study ID # | UCTH 2024 |
Secondary ID | |
Status | Not yet recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | March 2024 |
Est. completion date | July 2027 |
Vulnerable populations, who have deficient diets, may produce human milk (HML) that is not adequate in all nutrients and this will have consequences on the growth and development of the child. In 2021 at IDIP, a specific milk product for pregnant and lactating women Super Mil Mamá ( SMM, whole milk powder fortified with multiple vitamins, minerals and DHA ) has been designed and developed as part of a key strategy to incorporate in public policies for the first 1000 days of life. However, the potential benefits of this product have not yet been evaluated at the population level. The main objective is to evaluate the effect of the consumption of a milk product (SMM) designed for lactating women on the composition of human milk and the nutritional status of iron and DHA in infant red blood cells in a vulnerable population through a randomized, triple-blind, controlled clinical trial. Specific objectives To compare the concentrations of DHA, Vitamins A, E, and D, Iron, Iodine, Zinc and Calcium in human milk before and after dietary supplementation with SMM. To compare the concentrations of DHA, Vitamins A, E, D and Zinc in blood and the nutritional status of maternal iron before and after dietary supplementation with SMM. To analyze the relationship between micronutrients measured in maternal blood and human milk after dietary supplementation with SMM. To compare the concentrations of micronutrients measured in blood and human milk in women who received SMM and those who received commercial milk (CM) at the end of supplementation. To compare the iron nutritional status and DHA content in red blood cells of infants of mothers who consumed SMM or LC. To evaluate the relationship between the concentration of micronutrients in human milk and infant growth during the first six months of life.
Status | Not yet recruiting |
Enrollment | 120 |
Est. completion date | July 2027 |
Est. primary completion date | March 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Women who attend their child's first check-up within the first month of life, who breastfeed their children, and who consume milk regularly. Exclusion Criteria: - Women who have had multiple pregnancies, who receive vitamin or mineral supplements that interfere with the results of the study, and/or women with malabsorption diseases. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | breast milk DHA concentration | concentration of DHA in breast milk expressed as a percentage of DHA with respect to the total fatty acids contained in the analyzed sample | breast milk DHA concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Primary | breast milk Vitamin A concentration | Retinol concentration in breast milk expressed in µmol/L and µg/g fat contained in the analyzed sample | breast milk Vitamin A concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Primary | breast milk Vitamin E concentration | a-tocopherol concentration in breast milk expressed in µmol/L and µg/g fat contained in the analyzed sample | breast milk Vitamin E concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Primary | breast milk Vitamin D concentration | 25-hidroxi vitamin D concentration in breast milk expressed in ng/ml | breast milk Vitamin D concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Primary | breast milk Zinc concentration | Zinc concentration in breast milk expressed in mg/dl | breast milk Zinc concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Primary | breast milk Calcium concentration | Calcium concentration in breast milk expressed in mg/dl | breast milk Calcium concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Primary | breast milk Iron concentration | Calcium concentration in breast milk expressed in mg/dl | breast milk Iron concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Primary | breast milk Iodine concentration | Iodine concentration in breast milk expressed in mg/dl | breast milk Iodine concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Secondary | mother red blood cell DHA concentration | concentration of DHA in mother red blood cell expressed as a percentage of DHA with respect to the total fatty acids contained in the analyzed sample | mother serum DHA concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Secondary | mother Vit A concentration | Retinol concentration in mother serum expressed in µmol/L | mother Vit A concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Secondary | mother Vit E concentration | a-tocopherol concentration in mother serum expressed in µmol/L | mother Vit E concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Secondary | mother Vit D concentration | 25-hidroxi vitamin D concentration in mother serum expressed in ng/ml | mother Vit D concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Secondary | mother Zinc concentration | Zinc concentration in mother serum expressed in mg/dl | mother Zinc concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Secondary | mother hemoglobin concentration | hemoglobin concentration in mother serum expressed in g/dL | mother hemoglobin concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Secondary | mother serum ferritin concentration | ferritin concentration in mother serum expressed in ng/ml | mother serum ferritin concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Secondary | child hemoglobin concentration | hemoglobin concentration in child serum expressed in g/dL | child hemoglobin concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Secondary | child serum ferritin concentration | ferritin concentration in child serum expressed in ng/ml | child serum ferritin concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) | |
Secondary | child red blood cell DHA concentration | concentration of DHA in child red blood cell expressed as a percentage of DHA with respect to the total fatty acids contained in the analyzed sample | child red blood cell DHA concentration concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01953562 -
Positioning and the Spontaneous Breathing Test in Neonates
|
N/A | |
Completed |
NCT03716882 -
Acoustic Structures Crying of Infants From 1 to 4 Months and Their Signification
|
||
Recruiting |
NCT06353841 -
Effect of Therapeutic Touch on Functional Constipation in Infants and Young Children
|
N/A | |
Completed |
NCT06447558 -
The Effects of "Oral Administration of Breast Milk Droplets" and "Palatal Stimulation With a Finger"
|
N/A | |
Recruiting |
NCT05705258 -
A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)
|
||
Completed |
NCT02119104 -
Prevenar (13v) Infant Drug Use Investigation
|
N/A | |
Recruiting |
NCT06318858 -
Daily and Weekly Iron Supplementation in Infants
|
N/A | |
Not yet recruiting |
NCT03047876 -
Brain Vascular Reactivity to Hypothermic Circulatory Arrest With Antegrade Cerebral Perfusion During Aortic Arch Surgery
|
||
Withdrawn |
NCT05266677 -
DHA Proof-of-Concept Study in Infants and Toddlers
|
N/A | |
Recruiting |
NCT05940688 -
Providing an Optimized and emPowered Pregnancy for You (PᵌOPPY) Feasibility Study
|
N/A | |
Not yet recruiting |
NCT06127914 -
Learning Early Infant Feeding Cues
|
N/A | |
Completed |
NCT05492253 -
First Complementary Foods and the Infant Gastrointestinal Microbiota
|
N/A | |
Completed |
NCT03327415 -
Nutri-Bébé 2013 Survey on Food Consumption of Infants and Young Children
|
N/A | |
Completed |
NCT04598841 -
Nutrition Support for Hirschsprung Disease
|
N/A | |
Completed |
NCT01664234 -
Oxygen Insuflation and ArterialDesaturation During Tracheal Intubation in Children
|
N/A | |
Terminated |
NCT02069522 -
Healthy Term Infants Fed Milk-Based Formulas
|
N/A | |
Completed |
NCT04218929 -
Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants
|
N/A | |
Recruiting |
NCT01575184 -
Effect of Shoulder Traction on Size and Relative Position of Internal Jugular Vein to Carotid Artery
|
N/A | |
Not yet recruiting |
NCT05994417 -
Beyond Race: Objectively Assessed Skin Color and Its Association With Pulse Oximeter Bias in Critically Ill Infants
|